NR1H4 and metabolic disease: It has been speculated that the dynamic acetylation and deacetylation of FXR in normal mice are important for the activation of metabolic target genes, whereas in mice with metabolic diseases, constantly elevated acetylation blocks the transactivation of these genes [62].